JAZZ vs RHI · P/E 1988, rev $2.28B vs P/E 21, rev $5.38B
Jazz Pharmaceuticals PLC (JAZZ) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the JAZZ and RHI stock pages for the full models.
Not investment advice.